Can VEGF reverse diabetic neuropathy in human subjects?
Open Access
- 15 May 2001
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (10) , 1215-1218
- https://doi.org/10.1172/jci13038
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reversal of experimental diabetic neuropathy by VEGF gene transferJournal of Clinical Investigation, 2001
- Angiogenesis Is Induced in a Rabbit Model of Hindlimb Ischemia by Naked DNA Encoding an HIF-1α/VP16 Hybrid Transcription FactorCirculation, 2000
- Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscleJournal of Clinical Investigation, 2000
- Diabetic neuropathiesDiabetologia, 2000
- Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.Journal of Clinical Investigation, 1996
- Vascular Endothelial Growth Factor In Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersRetina, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB modelsDiabetologia, 1994
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Axonal atrophy in sensory nerves of the diabetic BB‐Wistar rat: A possible early correlate of human diabetic neuropathyAnnals of Neurology, 1983